Online catalogue

Hemo-Stop® Tabs

Tablet Oral

Dual Effect Antihemorrhagic

Formulation

Each tablet contains: Etamsylate 250 mg, Tranexamic acid 250 mg, Excipients q.s. 1 tablet.

Indications

Adjuvant in the treatment and control of hemorrhages. Control of hemostasis in traumatic, surgical, pathological processes and obstetric manipulations.

Dosage and Administration

Oral route. In general, at a rate of 10 to 12.5 mg of etamsylate and 10 to 12.5 mg of tranexamic acid/kg of body weight (1/2 tablet per 10 to 12.5 kg) every 6-8 hours until the desired effect is achieved. Administer for 1 to 5 days or until bleeding is controlled.